Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC), a particularly aggressive malignancy, has been linked to atypical levels, certain mutations, and aberrant signaling of G-protein–coupled receptors (GPCRs). GPCRs have been challenging to target in cancer because they organize into complex networks in tumor ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Jorand, Raphael, Biswas, Sunetra, Wakefield, Devin L., Tobin, Steven J., Golfetto, Ottavia, Hilton, Kelsey, Ko, Michelle, Ramos, Joe W., Small, Alexander R., Chu, Peiguo, Singh, Gagandeep, Jovanovic-Talisman, Tijana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Cell Biology 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221597/
https://www.ncbi.nlm.nih.gov/pubmed/27682590
http://dx.doi.org/10.1091/mbc.E16-06-0427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221597/
https://www.ncbi.nlm.nih.gov/pubmed/27682590
http://dx.doi.org/10.1091/mbc.E16-06-0427

Ejemplares similares